×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology
Session Chair(s)
Suanna S. Bruinooge, MPH
Chief and Division Director, Research Strategy and Operations Center
American Society of Clinical Oncology, United States
Improving access and minimizing burdens are critical to ensuring diverse representation in clinical trials. Panelists will discuss efforts to improve patient access to oncology clinical trials through streamlined protocols and decentralized elements.
Learning Objective : Describe the impact of incorporating decentralized elements (DE) into oncology clinical trials (CTs) on data integrity, patient safety and regulatory approvals; Explain how DE elements increase patient access and recognize opportunities to implement DE; Identify ongoing barriers to implementing DE into CT protocols and solutions to address operational challenges in expanding access to care.
Speaker(s)
How Sponsors, CROs, and Sites Can Work Together
Jane Elizabeth Myles, MSc
Decentralized Trials and Research Alliance, United States
Program Director
Meta-Analysis of Trials During COVID
Joseph Unger, PhD, MS
Fred Hutchinson Cancer Center, United States
Associate Professor
Implementing Trials in Large Healthcare System
Ramya Thota
Intermountain Medical Oncology - IMC, United States
Associate Professor
Have an account?